Embla Medical hf (OCSE:EMBLA) Cyclically Adjusted FCF per Share: kr1.26 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCSE:EMBLA Embla Medical hf OCSE:EMBLA
91 GF Score
Price kr28.50
GF Value kr34.11
Valuation Modestly Undervalued
View Full Analysis

What is Embla Medical hf Cyclically Adjusted FCF per Share?

Embla Medical hf OCSE:EMBLA -1.38% 91 Cyclically Adjusted FCF per Share is kr1.26 as of Jun. 2026. GuruFocus rates OCSE:EMBLA with a GF Score™ of 91/100 and a GF Value™ of kr34.11 (Modestly Undervalued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Embla Medical hf's adjusted free cash flow per share for the three months ended in Jun. 2026 was kr0.470. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is kr1.26 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Embla Medical hf's average Cyclically Adjusted FCF Growth Rate was 10.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 7.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Embla Medical hf was 10.40% per year. The lowest was 5.50% per year. And the median was 7.90% per year.

As of today (2026-08-05), Embla Medical hf's current stock price is kr28.50. Embla Medical hf's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was kr1.26. Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is 22.62.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 21.00. And the median was 41.44.


Embla Medical hf  (OCSE:EMBLA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Embla Medical hf's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=28.50/1.26
=22.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Embla Medical hf was 77.36. The lowest was 21.00. And the median was 41.44.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Embla Medical hf Cyclically Adjusted FCF per Share Related Terms


Embla Medical hf Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Embla Medical hf's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embla Medical hf Cyclically Adjusted FCF per Share Chart

Embla Medical hf Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.97 1.04 1.08 1.19

Embla Medical hf Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.15 1.19 1.20 1.26

OCSE:EMBLA vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Embla Medical hf's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Cyclically Adjusted Price-to-FCF falls into.


OCSE:EMBLA
91GF Score
Embla Medical hf OCSE:EMBLA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Embla Medical hf Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Embla Medical hf's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.47/161.3100*161.3100
=0.470

Current CPI (Jun. 2026) = 161.3100.

Embla Medical hf Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 0.248 102.457 0.390
201612 0.264 102.562 0.415
201703 0.035 102.768 0.055
201706 0.206 103.496 0.321
201709 0.210 103.871 0.326
201712 0.357 104.481 0.551
201803 -0.064 105.600 -0.098
201806 0.140 106.206 0.213
201809 0.270 106.727 0.408
201812 0.234 108.388 0.348
201903 0.063 108.702 0.093
201906 0.278 109.758 0.409
201909 0.580 109.922 0.851
201912 0.102 110.588 0.149
202003 0.266 111.019 0.386
202006 0.306 112.667 0.438
202009 0.334 113.772 0.474
202012 0.159 114.542 0.224
202103 0.142 115.833 0.198
202106 0.317 117.451 0.435
202109 0.196 118.723 0.266
202112 0.436 120.398 0.584
202203 0.076 123.555 0.099
202206 0.025 127.809 0.032
202209 0.212 129.810 0.263
202212 0.262 131.901 0.320
202303 -0.037 135.674 -0.044
202306 0.172 139.150 0.199
202309 0.287 140.147 0.330
202312 0.429 142.125 0.487
202403 -0.117 144.910 -0.130
202406 0.287 147.267 0.314
202409 0.513 147.722 0.560
202412 0.584 148.871 0.633
202503 0.121 150.393 0.130
202506 0.185 153.367 0.195
202509 0.566 153.800 0.594
202512 0.642 155.560 0.666
202603 0.059 158.510 0.060
202606 0.470 161.310 0.470

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of kr1.26 mean?
Embla Medical hf (OCSE:EMBLA) has a Cyclically Adjusted FCF per Share of kr1.26 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Cyclically Adjusted FCF per Share too high?
Embla Medical hf's current Cyclically Adjusted FCF per Share is kr1.26. Overall, Embla Medical hf has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Cyclically Adjusted FCF per Share compare to ABT and SYK?
Embla Medical hf's Cyclically Adjusted FCF per Share of kr1.26 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Cyclically Adjusted FCF per Share is kr1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Based on GuruFocus' analysis, Embla Medical hf (OCSE:EMBLA) is currently considered Modestly Undervalued. The stock's GF Value™ is kr34.11, compared to a current price of kr28.50 — trading 16.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is kr1.26. Embla Medical hf's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Embla Medical hf (OCSE:EMBLA), the current Cyclically Adjusted FCF per Share is kr1.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Embla Medical hf (OCSE:EMBLA) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of kr28.50 is trading 16.4% below its estimated GF Value™ of kr34.11. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for OCSE:EMBLA:

  • Cyclically Adjusted FCF per Share: kr1.26
  • GF Value™: kr34.11 vs. price of kr28.50 (16.4% below fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the OCSE:EMBLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Embla Medical hf Business Description

Other Exchanges 0FIW:UK5IQ:Germany
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
91GF Score

Get the complete analysis for OCSE:EMBLA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr28.50
Price
kr34.11
GF Value